EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.4.22.B60 | Breast Neoplasms |
9563472 |
Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 4 |
3.4.22.B60 | Carcinoma, Renal Cell |
9563472 |
Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 4 |
3.4.22.B60 | Colorectal Neoplasms |
9563472 |
Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 4 |
3.4.22.B60 | Neoplasms |
9563472 |
Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 4 |
3.4.22.B60 | Alopecia |
17942402 |
Cell type-specific functions of the lysosomal protease cathepsin L in the heart. |
causal interaction unassigned |
4 0 |
3.4.22.B60 | Neoplasms |
12874860 |
Electrophoretic analysis of the cleaved form of serpin, squamous cell carcinoma antigen-1 in normal and malignant squamous epithelial tissues. |
causal interaction unassigned |
4 0 |
3.4.22.B60 | Alopecia |
17934903 |
Evaluation of the CTSL2 Gene as a Candidate Gene For Alopecia X in Pomeranians and Keeshonden. |
causal interaction diagnostic usage ongoing research therapeutic application |
1 1 2 1 |
3.4.22.B60 | Endometrial Neoplasms |
22452389 |
Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 2 4 3 |
3.4.22.B60 | Infections |
32760059 |
Fasciola hepatica serine protease inhibitor family (serpins): Purposely crafted for regulating host proteases. |
therapeutic application unassigned |
1 0 |
3.4.22.B60 | Infections |
10425237 |
Immune responses of cattle to experimental anti-Fasciola hepatica vaccines. |
therapeutic application unassigned |
1 0 |